XML 63 R47.htm IDEA: XBRL DOCUMENT v3.25.3
Stock-Based Compensation (Tables)
 12 Months Ended
Sep. 27, 2025
Share-Based Payment Arrangement, Noncash Expense [Abstract]  
Schedule of Summary of Stock Options
Shares Under
Option		Weighted
Average Exercise
Price Per Share		Weighted Average Remaining Contractual Life (in Years)Aggregate
Intrinsic Value
(in millions)
Outstanding, September 28, 20247,114,663 $64.02 
Exercised(669,987)49.82 
Forfeited or expired(623,291)66.64 
Granted1,648,774 64.54 
Outstanding, September 27, 20257,470,159 $65.19 6.4$9 
Exercisable, September 27, 20254,851,416 $68.57 5.2$4 
Schedule of Assumptions of Fair Value Calculation of Each Year's Grants Assumptions used in the fair value calculation are as of the grant dates and are outlined in the following table.
202520242023
Expected life (in years)4.64.54.5
Risk-free interest rate4.2 %4.5 %3.9 %
Expected volatility26.8 %31.9 %31.2 %
Expected dividend yield3.0 %2.7 %2.9 %
Schedule of Summary of Restricted Stock
Number of 
Shares or Units		Weighted
Average Grant-
Date Fair Value
Per Share/Unit		Weighted Average
Remaining
Contractual Life
(in Years)		Aggregate
Intrinsic Value
(in millions)
Nonvested, September 28, 20241,866,591 $59.35 
Granted818,233 63.49 
Dividends65,562 59.72 
Vested(862,968)63.70 
Forfeited(191,133)58.38 
Nonvested, September 27, 20251,696,285 $59.26 1.4$92 
Schedule of Summary of Performance-Based Shares
The following table summarizes the performance-based shares at the maximum award amounts based upon the respective performance share agreements. Actual shares that will vest depend on the level of attainment of the performance-based criteria.
Number of SharesWeighted
Average Grant-
Date Fair Value
Per Share		Weighted Average
Remaining
Contractual Life
(in Years)		Aggregate
Intrinsic Value
(in millions)
Nonvested, September 28, 20242,375,302 $46.57 
Granted993,144 54.42 
Vested(220,933)48.74 
Forfeited(651,623)57.58 
Nonvested, September 27, 20252,495,890 $46.63 1.3$135